Last updated 2026-07-20
- Acquired by Galmed Pharmaceuticals Ltd. for $5.3M, Jun 2026
- Raised $9.3M Undisclosed Round led by European Innovation Council (EIC), Nov 2021
- Raised $7.7M Undisclosed Round led by Triventures, Aug 2017
Total raised
$17.0M
Last: Undisclosed Round 2021-12
Stage
Seed
Founded
2010
Headcount
11
HQ
Kfar Saba, Israel
Sector
Health Tech & Life Sciences
About
Colospan is a clinical-stage medical device company focused on developing proprietary technology for colorectal surgery. Its flagship product, CG-100, is a temporary intraluminal bypass device designed to protect colorectal anastomoses and reduce the need for diverting stomas. The company aims to improve clinical outcomes, simplify recovery, and reduce complications for patients undergoing colorectal surgery. Colospan's CG-100 is CE-marked in the EU and Israel, has received FDA Breakthrough Device Designation, and is approved for investigational use in the US.
Funding history · 3 rounds · $17.0M total
2021-11
Undisclosed Round
$9.3M
★ European Innovation Council (EIC)
2017-08
Undisclosed Round
$7.7M
★ Triventures★ Docor International Management★ Anatomy Medical Technology Fund★ Clal Biotechnology Industries (CBI)★ AMIT-Technion ( The Alfred Mann Institute)
2017-02
Grant
Undisclosed
Headcount over time
From 13 (2020-08) to 11 (2025-10) · -2 (-15%) · 14 points · source: Finder history + radar grounding
Q&A
- What is Colospan's primary focus?
- Colospan is a clinical-stage medical device company developing proprietary technology for colorectal surgery to prevent anastomotic leaks and divert colonic stomas.
- When was Colospan founded?
- Colospan was founded in December 2010.
- What is the status of Colospan?
- Colospan has been acquired by Galmed Pharmaceuticals in June 2026.
- What was Colospan's most recent funding round?
- Colospan raised $9.3 million in a private funding round in December 2021, with the European Innovation Council (EIC) as an investor.
- Who are the lead investors in Colospan's September 2017 funding round?
- In September 2017, Colospan secured $7.7 million in a private funding round with investors including Anatomy Medical Technology Fund.
- Who is the Founder & CEO of Colospan?
- Boaz Assaf is the Founder & CEO of Colospan.
- Where is Colospan's headquarters located?
- Colospan's headquarters is located in Kefar Sava, Israel.
Team · 2
Boaz Assaf
Founder · Founder & CEO
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B
Highlights
1 PatentsVerified
Tags
gastroenterologysurgerymedical-devicessurgical-instrumentssurgeonspreventiontreatmentscancercolonoscopyhospitals
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | colospan.com/ |
|---|---|
| linkedin.com/company/68366723 | |
| facebook.com/colospan | |
| YouTube | youtube.com/channel/UCGwTqu2jGBrH6cekUgWUEAA |
Identifiers & details
| Legal name | Colospan Ltd. |
|---|---|
| Former names | Cologuard |
| Founded | 2010 |
| Employees (exact) | 11 |
| Offices | Cambridge |
Acquisitions & public offerings
Acquired by Galmed Pharmaceuticals Ltd. 2026-06 $5.3M
Radar intelligence
Patents
| EPO | 4 |
|---|
Web history (Wayback)
| Domain | colospan.com |
|---|
Certificate / subdomain footprint
| Subdomains | 2 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 514525971 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2010-11-28 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2026 |
| Active charges / liens | 0 |
| Registry events | 2 — annual_report (1), people (1) |
| Registered address | עתירי ידע 21 כפר סבא |
Recent registry events
| Date | Event |
|---|---|
| 2026-02-10 | דו~ח שנתי |
| 2026-02-08 | עדכון בעלי תפקידים |